Glyap1 regulates pneumocandin B0 synthesis by controlling the intracellular redox balance in Glarea lozoyensis
Pneumocandin B 0 , the precursor of the antifungal drug caspofungin, is a lipohexapeptide produced by the fungus Glarea lozoyensis . Oxidative stress and the resulting production of reactive oxygen species (ROS) are known to be involved in the regulation of pneumocandin B 0 biosynthesis. In this stu...
Saved in:
Published in | Applied microbiology and biotechnology Vol. 105; no. 18; pp. 6707 - 6718 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.09.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pneumocandin B
0
, the precursor of the antifungal drug caspofungin, is a lipohexapeptide produced by the fungus
Glarea lozoyensis
. Oxidative stress and the resulting production of reactive oxygen species (ROS) are known to be involved in the regulation of pneumocandin B
0
biosynthesis. In this study, the Gl
yap1
gene of
Glarea lozoyensis
, a homologue of the yeast redox regulator YAP1, was knocked out. The intracellular ROS levels of the resulting ΔGl
yap1
strain were higher than in the wild-type strain, which was caused by the downregulated expression of superoxide dismutase (SOD) and catalase (CAT). Compared with the wild-type strain, ΔGl
yap1
exhibited an oxidative phenotype throughout its life cycle, which resulted in significantly higher pneumocandin B
0
production per unit biomass. In addition, ΔGl
yap1
showed growth inhibition and decreased pneumocandin B
0
production in the presence of CCl
4
, which leads to strong oxidative stress. To overcome the strain’s sensitivity, a three-stage antioxidant addition strategy was developed. This approach significantly improved the growth of ΔGl
yap1
while maintaining a high pneumocandin B
0
production per unit biomass, which reached 38.78 mg/g DCW. Notably, this result represents a 50% increase over the wild-type strain. These findings provide new insights into the regulatory mechanisms that control pneumocandin B
0
production under oxidative stress, which may be applied to improve the production of other secondary metabolites.
Key points
•
Glyap1 is involved in expression of redox and pneumocandin B
0
synthesis-related genes.
•
Addition of a three-stage antioxidant alleviated the sensitivity of ΔGlyap1 strain.
•
The yield of pneumocandin B
0
per unit biomass of ΔGlyap1 strain was 38.78 mg/g DCW. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0175-7598 1432-0614 |
DOI: | 10.1007/s00253-021-11522-5 |